SCROLL
R&D
Immune Disease Division
Inflammatory autoimmune diseases are caused by disruption of immune
homeostasis, which is finely controlled by immune cell responses.
Neurological Disease Division
Central Research Institute (CRI) aims to develop promising peptide drugs for treating
neuroinflammatory diseases with special focus on Alzheimer’s disease, the leading cause
of dementia in old age.
Immune Disease Division
Inflammatory autoimmune diseases are caused
by disruption of immune homeostasis,
which is finely controlled
by immune cell responses.
by disruption of immune homeostasis,
which is finely controlled
by immune cell responses.
Neurological Disease Division
Central Research Institute (CRI) aims to develop
promising peptide drugs for treating
neuroinflammatory diseases with special focus on
Alzheimer’s disease, the leading cause
of dementia in old age.
promising peptide drugs for treating
neuroinflammatory diseases with special focus on
Alzheimer’s disease, the leading cause
of dementia in old age.
PIPELINE
PIPELINE
Detail
Autoimmune
- Rheumatoid Arthritis (RA)
- KINE-101A
- Inflammatory Bowel Disease (IBD)
- KINE-101B
PNS
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- KINE-101C
Metabolite
- Non-Alcoholic Steatohepatitis (NASH)
- KINE-101D
Dermatology
- Atopic dermatitis
- KINE-201A
Respiratory
- Asthma
- KINE-201B
- Chronic Obstructive Pulmonary Disease (COPD)
- KINE-201C
Dermatology
- Psoriasis
- KINE-301A
Cancer
- Solid tumor
- KINE-401A
CNS
- Alzheimer's disease
- KINE-501A
- Frontotemporal Dementia (FTD)
- KINE-501B
- Lewy Body Dementia (LBD)
- KINE-501C
- Parkinson's disease
- KINE-501D
Other
- Wound healing
- KINE-601A
- Alopecia
- KINE-601B
News & Notice
News and information
from Kine Sciences
from Kine Sciences
